Fibrillation inhibitors containing sphingosine-1-phosphate receptor agonists or sphingosine-1-phosphate as active components

• 1. 鞘氨醇-1-磷酸4受体激动剂及其与真武汤联合在制备治疗慢性肾小球肾炎药物中的应用 [P] . 中国专利： CN113332435A . 2021-09-03
• 2. 鞘氨醇-1-磷酸酯受体激动剂、其制备方法以及包含其作为活性剂的药物组合物 [P] . 中国专利： CN105051037B . 2018.05.18
• 3. FIBROSIS INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR SPHINGOSINE-1-PHOSPHATE [P] . 欧洲知识产权局专利： EP1195165A4 . 2005-08-10

  机译： 活性成分为新蛋白-1-磷酸受体激动剂或新蛋白-1-磷酸的成纤维抑制剂

• 4. FIBROSIS INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR SPHINGOSINE-1-PHOSPHATE [P] . 欧洲知识产权局专利： EP1195165A1 . 2002-04-10

  机译： 活性成分为新蛋白-1-磷酸受体激动剂或新蛋白-1-磷酸的成纤维抑制剂

• 5. -1- -1- FIBROSIS INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR SPHINGOSINE-1-PHOSPHATE [P] . 韩国专利： KR20020027463A . 2002-04-13

  机译： -1- -1-含有活性成分辛基磷酸-1-磷酸受体激动剂或鞘氨醇-1-磷酸的成纤维抑制剂

• 1. Harnessing sphingosine-1-phosphate signaling and nanotopographical cues to regulate skeletal muscle maturation and vascularization [C] . Jonathan H. Tsui, Kajohnkiart Janebodin, Nicholas Ieronimakis, Society for Biomaterials annual meeting and exposition . 2017
• 2. Synthesis and biological evaluation of conformationally constrained sphingosine-1-phosphate analogs as subtype selective S1P receptor agonist/antagonist. [D] . Zhu, Ran. 2008
• 3. Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase [O] . Hsueh-Chun Wang, Tzu-Hsuan Wong, Li-Ting Wang, 2019
• 4. Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase [O] . Hsueh-Chun Wang, Tzu-Hsuan Wong, Li-Ting Wang, 2018

• 1. Expressions of Sphingosine-1-phosphate (S1P) Receptors, Sphingosine Kinases in Malignant Bone and Soft Tissue Tumors, and The role of Sphingosine Kinase-1 in Growth of MFH Cell Lines [J] . Shin-ichiro Kishimoto ,Toshihiro Akisue ,Kenta Kishimoto . 癌症治疗（英文） . 2011,第2期
• 2. Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells [J] . Mei Li Ng ,Nagendra S Yarla ,Mario Menschikowski . 世界干细胞杂志：英文版（电子版） . 2018,第9期
• 3. Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome [J] . Sanjay Chatterjee ,Samit Ghosal ,Saurav Chatterjee . 世界糖尿病杂志：英文版（电子版） . 2016,第18期
• 4. Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting? [J] . Maja Cigrovski Berkovic ,Ines Bilic-Curcic ,Tomislav Bozek . 世界糖尿病杂志：英文版（电子版） . 2020,第11期
• 5. Review on the Effect of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Non-Alcoholic Fatty Liver Disease [J] . Chao-lin LI ,Lu-jie ZHAO ,Xin-li ZHOU . 华中科技大学学报（医学）（英德文版） . 2015,第003期
• 6. 姜黄素通过鞘氨醇激酶-1-磷酸鞘氨醇信号通路抗糖尿病大鼠肾脏纤维化的研究 [C] . 郝洁 ,李婕 ,黄河清 . 第十三届中南地区实验动物科技交流会 . 2013
• 7. HDL上调脐静脉内皮细胞COX-2表达依赖鞘氨醇激酶2和1-磷酸鞘氨醇受体途径 [A] . 熊升林 . 2014